Market Outlook
Hypodontia or selective tooth agenesis is the failure to form one or more teeth during the developmental period. 2.6%–11% of the population across the globe suffers from this condition. The exact cause of the condition remains unknown. Increasing number of patients suffering from hypodontia drives the growth of the market. Additionally, increasing prevalence of different dental diseases have increased the demand for different treatments and boosted the growth of the market. During last decade, a number of different treatments and diagnostic devices were introduced to improve the prognosis of the condition. Well developed technology has supported the growth of the market in this region, however, high cost of the treatment may slow the market growth.
The global hypodontia market is expected to grow at a CAGR of 6.2% during the forecast period 2017-2023.
Get Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5044
Segmentation
The global hypodontia market is segmented on the basis of causes, treatment, and end users.
On the basis of the causes, the market is segmented hormonal defects, infection, genetics, environmental, and others. Hormonal defects is further segmented into idiopathic hypoparathyroidism and pseudohypoparathyroidism. Infection is further segmented into rubella, candida, and others. Genetics is sub segmented into MSX1 and PAX9.
On the basis of the treatment, the market is segmented into paediatric dentistry, restorative dentistry, orthodontics, oral surgery, and others.
On the basis of the end users, the market is segmented into hospital & clinics, dental centers, and others.
Regional Analysis
The Americas dominate the global hypodontia market owing to a large patient population, strong government support for research & development, and high healthcare spending. Additionally, increasing awareness has fuelled the growth of the market.
Europe is the second leading global hypodontia market which is followed by Asia Pacific which is the fastest growing market for hypodontia. Asia Pacific hypodontia market is majorly driven by India, and China owing to a huge patient pool, presence of huge opportunity for the market development and continuously developing healthcare sector.
The Middle East and Africa contribute the least in the growth of global hypodontia market. Among the Middle East and Africa, the Middle East dominates the market of which the UAE, Saudi Arabia, and Kuwait are expected to be the major contributors.
However, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition. However, expected growth of the African market is high due to the presence of opportunities for the development of the market.
Brows Complete Premium Research at https://www.marketresearchfuture.com/reports/hypodontia-market-5044
Key Players
The key players for the global hypodontia market are Patterson Dental (U.S.), Henry Schein (U.S.), Dentsply Sirona (U.S.), 3M (U.S.), Pfizer (U.S), Bayer AG (Germany), Straumann (Switzerland), Danaher Corporation (Switzerland), PLANMECA OY (Finland), Carestream Health, Inc. (U.S), Biolase Inc (U.S), KERR Corporation (U.S), GC orthodontics (Germany),, and American Orthodontics (U.S).
